Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Tvardi To Contact Him Directly To Discuss Their Options If you suffered significant losses in Tvardi stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York--(Newsfile Corp. - December 18, 2025) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Tvardi Therapeutics, Inc. ("Tvardi" or the "Company") (NASDAQ: TVRD).

ARLINGTON, Va.--(BUSINESS WIRE)--Accenture Federal Services, a wholly owned subsidiary of Accenture (NYSE: ACN), announced today its agreement to explore partnerships with the U.S. Department of Energy (DOE) to support the Genesis Mission. This era-defining initiative is a national imperative that will accelerate American leadership in the global Artificial Intelligence (AI) race and fundamentally transform the nation's science and technology ecosystem. The Genesis Mission, led by the DOE, seek.

Amazon.com Inc (NASDAQ:AMZN) stock was last seen up 2.5% at $226.70, after a strong 2026 outlook from Truist Securities.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Above Food Ingredients Inc. (“Above Food” or the “Company”) (NASDAQ: ABVE) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ABOVE FOOD INGREDIENTS INC. (ABVE), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On December 2, 2025, Above Food disclosed that.

In mid-December 2025, the stock market experienced a significant psychological shift. High-flying semiconductor stocks, which had led the market for months, faced heavy selling pressure following earnings reports from major tech players like Oracle NYSE: ORCL and Broadcom NASDAQ: AVGO.

The Oncology Institute recently achieved its first profitable Adj. EBITDA for the month and posted 37% YoY revenue growth, beating consensus by $13.9M. TOI raised FY25 guidance to $500M revenue and expects positive Adj. EBITDA in Q4, with cash flow positivity likely by mid-2026. Despite a massive share price surge in 12 months, GAAP EPS profitability remains two years away; consolidation is expected before a favorable entry point.

Okeanis Eco Tankers is a Buy, driven by fleet modernization, immediate commercial upside, and aggressive capital return policies. ECO's Q4 VLCC rates of $88,100/day, 100% eco-scrubber fleet, and $8.2M EBITDA uplift create near-term earnings torque and margin expansion. Despite premium valuation and dilution from a $35.5/share offering, high dividend payout (~90-100%) and operational leverage support the investment case.

Day One Biopharmaceuticals, Inc. is gaining momentum after Ojemda's strong Q3 launch, with revenues up 15% sequentially and full-year guidance raised to $145–$150m. DAWN's Ojemda is the only therapy specifically approved for PLGG, with a chance to become standard of care and ongoing Phase 3 front-line study. Strategic moves include acquiring Mersana Therapeutics for ADC pipeline expansion and a lucrative partnership with Ipsen for ex-US commercialization.

New York, New York--(Newsfile Corp. - December 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Stride, Inc. (NYSE: LRN) and certain of the Company's senior executives for securities fraud after significant stock drops resulting from the potential violations of the federal securities laws. If you invested in Stride, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/stride-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Synopsys, Inc. (NASDAQ: SNPS) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Synopsys, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/synopsys-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. (NYSE: ARE) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Alexandria Real Estate, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/alexandria-real-estate-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Integer Holdings Corporation (NYSE: ITGR) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Integer, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/integer-holdings-corporation-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against James Hardie Industries plc (NYSE: JHX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in James Hardie, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/james-hardie-industries-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in CarMax, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/carmax-inc-class-action-lawsuit.

New York, New York--(Newsfile Corp. - December 18, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Inspire, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/inspire-medical-systems-inc-class-action-lawsuit.

Plenty of attention from advisors and investors has been focused on gold, silver, and copper as of late, but those aren't the only metals worth looking at. One metal that may be flying under the radar for many investors and advisors is lithium.

LAS VEGAS--(BUSINESS WIRE)--JW Marriott Las Vegas and Rampart Casino today announced a property-wide rebrand, officially uniting the celebrated resort and casino under a new identity, The Resort at Summerlin. Effective January 1, 2026, the rebrand marks a significant milestone in the property's ongoing $75 million, multi-year renovation and its evolution as a premier luxury destination in the heart of Summerlin. The extensive renovation reflects a renewed focus on mindful luxury, well-being, an.

Salesforce Inc (NYSE: CRM) is being valued like a mature enterprise software name just as artificial intelligence begins to reshape how its platform is used — and monetized. JPMorgan argues that the disconnect has created one of the most mispriced opportunities in large-cap software.

One of the most important stocks in the market, and still one of the most valuable companies in the world, Apple (NASDAQ:AAPL) is a company I'd argue investors can't ignore.

President Donald Trump on Thursday signed an executive order directing the federal government to move marijuana from Schedule I to Schedule III, potentially easing regulatory and financial constraints for cannabis companies while keeping recreational use illegal under federal law. The order instructs the attorney general to expedite the ongoing process of rescheduling marijuana, which is currently classified alongside heroin and LSD as a Schedule I drug — considered to have a high potential for abuse and no accepted medical use.